BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  CTI BioPharma Release: PERSIST-2 Phase 3 Study Of Pacritinib Versus Best Available Therapy Shows Encouraging Clinical Activity In High-Risk Patients With Advanced Myelofibrosis In Late-Breaking Session At American Society of Hematology Annual Meeting

  December 6, 2016

   · 

  13 min read
• Drug Development

  Auris Med On Track To Resume Enrollment Of Keyzilen Tinnitus Program Following Regulatory Feedback

  December 6, 2016

   · 

  3 min read
• Owlstone Medical’s Reciva Named Invention Of The Year In Top 50 Digital Health Awards

  December 6, 2016

   · 

  1 min read
• Drug Development

  MorphoSys AG Presents Updated Clinical Results For Anti-CD38 Antibody MOR202 At American Society of Hematology 2016

  December 6, 2016

   · 

  4 min read
• Drug Development

  EyeGate Pharma Reports Positive Data From Third Stage Of Phase 1b/2a Clinical Trial Of EGP-437 In Cataract Surgery Patients

  December 6, 2016

   · 

  3 min read
• Drug Development

  Kiadis Pharma Presents Positive 1-Year Follow-Up Data Of Its Pivotal Phase II Trial With ATIR101

  December 6, 2016

   · 

  11 min read
• Drug Development

  Juno Presents Data From TRANSCEND Study Showing 60% Complete Response In Patients With Relapsed Or Refractory Aggressive CD19+ Non-Hodgkin Lymphoma

  December 6, 2016

   · 

  7 min read
• Drug Development

  Boston Biomedical Announces First Clinical Data For Investigational WT1 Cancer Peptide Vaccine, DSP-7888, At American Society of Hematology Annual Meeting & Exposition

  December 6, 2016

   · 

  6 min read
• Biotech Bay

  Sutro Biopharma ADC Targeting CD74 Exhibits Potent Anti-Tumor Activity In Multiple Malignant Cell Lines And Animal Models Of Non-Hodgkin Lymphoma And Multiple Myeloma

  December 6, 2016

   · 

  2 min read
• Deals

  Sienna Biopharma Acquires Creabilis plc

  December 6, 2016

   · 

  4 min read